Products & Services Pay Your Bill Check Your Email Your Community Portal
ADVERTISEMENT

Custom Search
ADVERTISEMENT
Today's Health Headlines
WASHINGTON (Reuters) - Details of potential Obamacare replacements by U.S. House Republicans emerged in news reports on Friday, as Republican lawmakers have vowed to introduce new legislation in the coming weeks.

(Reuters) - Pfizer Inc said it received subpoenas from the U.S. Attorney's Office for the District of Massachusetts related to its support for organizations that provide financial help to Medicare patients.

NEW YORK (Reuters) - Proposals in Congress that would effectively end Medicaid expansion in 31 U.S. states would cost those states at least $32 billion altogether in 2019, according to a report released on Friday.

WASHINGTON (Reuters) - A majority of Americans say it is important to keep federal funding for an expansion of the Medicaid program for the poor under Obamacare, even as Republicans work on repealing and replacing former President Barack Obama's healthcare law, according to a poll released on Friday.

ATLANTA (Reuters) - The number of deadly heroin overdoses in the United States more than quadrupled from 2010 to 2015, a federal agency said on Friday, as the price of the drug dropped and its potency increased.

(Reuters Health) - For mountain climbers and hikers, injuries often include broken bones, sprains and skin wounds, but many don’t carry the right supplies for the injuries and illnesses they are most likely to face, a recent study found.

Not all bug repellents are equal
Fri, 24 Feb 2017 16:49:39 -0500
(Reuters Health) - Pay attention to the ingredients of bug sprays and other repellents, because they're not equally effective at warding off mosquitoes that carry diseases like Zika virus, researchers say.

WASHINGTON (Reuters) - The administration of President Donald Trump may ramp up enforcement of federal laws against recreational marijuana use, a White House spokesman said on Thursday, setting up potential conflicts in states where the drug is legal.

ZURICH (Reuters) - Swiss drugmaker Novartis's drugs Tafinlar and Mekinist edged closer to approval in Europe to be used together against a type of lung cancer after a key committee on Friday published a recommendation to expand the combination's indications.

NEW YORK (Reuters) - A New York state judge has dismissed a lawsuit accusing the Sequoia Fund, known for its ties to Warren Buffett, of recklessly making a huge, disastrous investment in Valeant Pharmaceuticals International Inc , causing billions of dollars of losses.

ADVERTISEMENT
Portal Login
Email: 
Password:
Not a member?
Browse RSS Feeds
click here when finished
Save Page Layout
loading
Unable to open file.